Skip to main content
Secukinumab shows benefit for hidradenitis suppurativa out to 52 weeks
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Secukinumab shows benefit for hidradenitis suppurativa out to 52 weeks
User login
Username
Password
Reset your password
Concept
Lead
score
Biologic Therapy
1
1
Hidradenitis Suppurativa
0
0.99
Skin and Soft Tissue Infection
0
0.54
Europe
0
0.46
Imbalance
0
0.46
Pain
0
0.46
Washington
0
0.46
Otolaryngology
0
0.33
Pain Management
0
0.27
Psoriasis
0
0.27
Clinical Research
0
0.23
Interleukin
0
0.23
Match
0
0.23
Nasopharyngitis
0
0.23
Tumor
0
0.23
Headache
0
0.14
Healthcare and Medical Technology
0
0.14
Specialty
Lead
score
Dermatology
1
1
Family Medicine/Primary Care
0
0.9
Edit Tags